BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2008
View Archived Issues
Selective immunoproteasome inhibition with PR-957 beneficial in models of rheumatoid arthritis
Read More
CBP-501 well tolerated alone and with cisplatin in phase I solid tumor studies
Read More
New phase I and II data on BIBW-2992 reported
Read More
Recent patents disclose new therapeutic agents for obesity and nutrition disorders
Read More
Efficacy of golimumab in rheumatoid arthritis demonstrated in phase III studies
Read More
Cogentus enrolls first European patient in pivotal phase III CGT-2168 trial
Read More
Exelixis and FDA agree on Special Protocol Assessment for XL-184 phase III trial
Read More
Metabolex completes patient enrollment in phase II MBX-8025 trial
Read More
JX-594 well tolerated, active in refractory primary and metastatic liver cancer
Read More
CSL receives Australian approval to register Panvax avian flu vaccine
Read More
Novartis withdraws MAA for pre-pandemic vaccine Aflunov
Read More
Humira subcutaneous injection now available in Japan for rheumatoid arthritis
Read More
ARYx Therapeutics commences phase II/III trial comparing ATI-5923 to warfarin
Read More
Genzyme files Mozobil marketing applications in the United States and Europe
Read More
Oncothyreon initiates phase I PX-866 trial in patients with solid tumors
Read More
Adventrx reports CoFactor phase IIb overall survival results
Read More
Obese patients treated with liraglutide for 1 year show significant weight loss
Read More
Elan and Wyeth present top-line results from phase II bapineuzumab trial in AD
Read More
Lipoxen is granted Canadian approval to initiate phase I trial of ErepoXen for anemia
Read More
Takeda requests reexamination of negative opinion for ramelteon given by EMEA's CHMP
Read More
Bayer Yakuhin and Mitsubishi Tanabe enter joint marketing agreement for Glucobay
Read More
Novel antibacterial agents disclosed in recent Actelion patent
Read More
Recent Concert patent reports new anti-HIV agents
Read More
Spectrum selects Fusilev as tradename for levoleucovorin for injection
Read More
FDA Advisory Committee recommends approval of ustekinumab
Read More
Pharming reports positive results from North American trial of Rhucin in HAE
Read More